/WP/wp-content/uploads/colorectal_cancer.png

Innovation in Colorectal Cancer: Prevention, Treatment, and Cost of Care

In 1999, Prevent Cancer Foundation, a Project Innovation member, led a group of professional and patient groups, including Colon Cancer Alliance and Fight Colorectal Cancer, to designate March 2000 as the first Colorectal Cancer Awareness Month. Prior to that designation, there was very little awareness about this ...

Continue reading
/WP/wp-content/uploads/Defining_Value_Header.png

In Cancer Care, Who Defines Value?

Cancer kills nearly 1,600 Americans every day, translating to almost 25 percent of deaths in the United States and approximately $200 billion in health care costs annually. With numbers like these, it’s no question that cancer impacts everyone – from patients and their loved ones to pharmaceutical companies and the economy. However, with so many stakeholders to consider, how do we truly measure value in cancer care, and which definition should be at the forefront of the ...

Continue reading
/WP/wp-content/uploads/PI-Moonshot-Header.jpg

Cancer Moonshot: What’s Next In a Transitioning Administration?

Just over a year ago, on January 12, 2016, former President Barack Obama announced the Cancer Moonshot effort as part of his final State of the Union address. Since that time, former Vice President Joe Biden has worked to build structure and support that will accelerate cancer research to ultimately bring more effective treatments to cancer patients.

Work to date has included the release of a

Continue reading
/WP/wp-content/uploads/PI-Infographic-Journey-of-Medicine-Header.png

The Journey of a New Cancer Medicine

From the first chemotherapy in 1949 to the newest targeted treatments, breakthrough medicines have transformed cancer care. Between 1988 and 2000, the life expectancy for cancer patients increased by approximately four years—translating to roughly 23 million additional life years and $1.9 trillion in value added to the economy. This shift represents the results of not only breakthrough discoveries but also a series of smaller medical advances over time.

While ...

Continue reading
/WP/wp-content/uploads/Bill_Nack_Blog_Post.jpg

Immunotherapy: The Hail Mary Pass to Bill’s Survival

A lesson often learned through sports is to dust yourself off and keep going. Whether you are a professional boxer, a first-time little leaguer, or simply an arm chair quarterback, these words of advice are tried and true.

Bill Nack – author, journalist, sportswriter, and horse racing enthusiast – learned firsthand the importance of getting up and staying in the race.

Born in Chicago, Bill studied communications at the University of Illinois ...

Continue reading
/WP/wp-content/uploads/Thankful_For_Innovation.png

Thankful for Innovation

As the holiday season draws near, we reflect on the things that make us thankful: time spent with loved ones, achievements and milestones reached throughout the year, the promise of another day. 

When it comes to innovation in cancer, we have much to be thankful for:

Clinical trials and research participants: Clinical trials are at the heart of delivering breakthrough medicines to patients and saving lives, and make it possible for patients to receive state-of-the-art ...

Continue reading
/WP/wp-content/uploads/Transparency.png

Increasing Clinical Research Access and Transparency

Clinical trials are at the heart of delivering breakthrough medicines to cancer patients and are essential to furthering progress in preventing and treating cancer. However, fewer than five percent of adult cancer patients participate in clinical trials, generally due to some common misperceptions about how these studies are conducted. And while the medical benefits of new cancer treatments are routinely reported, adverse events or side effects ...

Continue reading
/WP/wp-content/uploads/defining_value.png

Defining Value and Patient-Centered Care

Medical innovation saves lives, enhances quality of life, improves public health, and adds economic value to society. But when it comes to assessing the value of medical innovation, patients, policymakers, industry representatives, and insurance companies often evaluate it differently with diverse perspectives.

Historically, a number of decisions doctors and patients make about a person’s medical treatment are oftentimes determined by care plans called

Continue reading
/WP/wp-content/uploads/moonshot-02-1.png

Investing in a Cancer Moonshot

On June 29, Vice President Biden joined more than 350 researchers, oncologists, patient advocates, technology experts, and care providers at Howard University for the first-ever Cancer Moonshot Summit. The Summit was a national day of action, with more than 260 virtual  events also taking place outside of DC. From Miami, Florida to Anchorage, Alaska; Lexington, Kentucky to Biden’s hometown of Wilmington, Delaware, more than 6,000 individuals nationwide discussed the necessary ...

Continue reading
/WP/wp-content/uploads/PI_FORCE.png

FORCE Releases Survey for Those at Risk of Hereditary Cancers

For those at high-risk of hereditary cancers, regular screening and other measures of preventive care can make a world of difference. But access to treatment isn’t always simple. Without stronger Federal involvement, many insurance companies do not consider preventive care necessary, and therefore decline to cover the cost.

Through harnessing the feedback of patients’ experiences with barriers to insurance coverage, Facing Our Risk ...

Continue reading

More from the blog:

Join the Movement

Sign up to receive emails from Project Innovation and become a part of the movement to accelerate cancer breakthroughs.

We will not share your contact information with third parties.

Share Your Story

Have a cancer story? Help us illustrate the impact of medical innovation by sharing your story here.